Entacapone is an inhibitor of the enzyme catechol-O-methyltransferase (COMT) which methylates polyphenols and so its use in combination with ACNs promoted a synergetic effect in the growth inhibition of CC and BC cells. The gene discussed is COMT; the disease is breast cancer.